WHO estimates funds for eliminating measles in India
World Health Organization (WHO) estimates that around $800 million is required to eliminate measles by 2020 from India and other countries of south and south east Asia. Measles is one of the major causes of death in children, MMR (measles, mumps and rubella) jabs are one of the major public health interventions aimed at eliminating childhood deaths. For unhampered progress against the viral disease, WHO states that a total of 400 million children in India, Bangladesh, Myanmar, Timor Leste and Indonesia must receive the Measles Rubella (MR) vaccine by 2018, while 140 million should be reached by the end of 2017. In 2015, the National Technical Advisory Group on Immunization in India recommended introduction of a combined measles-rubella vaccine, as a nation-wide campaign covering children in the age group of nine months to 15 years.
After the campaign, the MR vaccine will replace the current two doses of measles vaccine. The ongoing MR campaign in five states and union territories—Tamil Nadu, Karnataka, Goa, Puducherry and Lakshadweep—to vaccinate 34.8 million children, has till date, reached 11.6 million children.